Tag: Novanax
Pooling Technological Prowess to Take Charge Against the Overpowering Challenge of Covid-19
Novanax, a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has officially announced a co-exclusive licensing agreement with Sanofi. Under the agreed terms,...